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Background & Aims: Non-alcoholic fatty liver disease (NAFLD) is one of the most 
prevalent liver diseases. Recent studies have shown that cholesterol is accumulated in 
liver during the progression of NAFLD. Thus, increasing attention has been drawn to 
the role of cholesterol in the pathogenesis of the disease. Autophagy, a cellular 
degradative pathway, is an important self-defense mechanism to maintain cellular 
homeostasis in response to various stresses including lipid stimulation. In this context, 
this study was undertaken to determine cholesterol lipotoxicity in hepatocytes using 
cholesterol overloaded HepG2 cells. Precisely, whether dysregulated cholesterol 
homeostasis alters autophagic activity and contributes to apoptosis was investigated. 
 Methods: Human hepatocarcinoma cell line, HepG2 cells were treated with cholesterol 
with either 25 or 50 µg/mL of concentrations, which are considered to deposit cholesterol 
as much as the amount found in human and experimental NAFLD model. Additional 
treatment using 10µM chloroquine was conducted in some experiments to inhibit 
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lysosomal activity and degradation of autophagosome. Intracellular cholesterol level was 
measured by enzymatic colorimetric methods and the cell viability was determined 
through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. 
The relative levels of several autophagy or apoptosis related proteins were analyzed by 
Western blotting. Production of reactive oxygen species (ROS) was assessed by 
observing emission of green fluorescence following oxidation of 2,7-
dichlorofluorescein diacetate. Lipid peroxide levels were determined by measuring 
cellular thiobarbituric acid reactive substances (TBARS) levels. 
 Results: Intracellular total cholesterol level increased in cells treated with 50 µg/mL 
cholesterol after 24 hours compared with vehicle treated cells. MTT assays showed dose-
dependent cholesterol toxicity and microscopic observations showed reduction of cell 
populations compared with vehicle control cells when 25 or 50 µg/mL of cholesterol 
were treated. Detection of cleavage of non-erythroid spectrin and caspase-3 revealed that 
cholesterol treatment prominently induced the apoptosis in HepG2 cells. Meanwhile, 
regarding autophagy pathway, treatment of cholesterol induced the increases of LC3-II 
and p62 protein levels dose-dependently. Beclin-1 remained unchanged. Moreover, in a 
LC3-II turnover assay, cells treated with chloroquine plus cholesterol showed less LC3-
II degradation than those with chloroquine alone. Cholesterol also resulted in 
concomitant increase of ubiquitinated protein levels. Thus, these data collectively 
indicated that cholesterol treatment reduced autophagic flux. To clarify whether defects 
in autophagy is the primary cause of cholesterol induced caspase-3 activation, cell 
viability was measured using MTT assay after chloroquine or/and cholesterol treatment. 
As a result, 10 µM chloroquine treatment induced 10.7% viability loss while 50 µg/mL 
cholesterol treatment 44.6% viability loss, despite similar level of autophagy inhibition. 
Thus, it can be inferred that blockage of autophagic flux is not enough to cause systemic 
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cell death, unless other toxic mechanisms are involved. Production of ROS and induction 
of lipid peroxides were observed after 50 µg/mL of cholesterol were treated, suggesting 
cholesterol accumulation induced oxidative stress. Activation of c-Jun N-terminal kinase 
(JNK) was also detected following the cholesterol loading. Furthermore, mitochondrial 
dysfunction which is strongly associated with oxidative stress was confirmed by 
detection of cleavage of caspase-9. Increased phosphorylation level of adenosine 
monophosphate-activated kinase (AMPK) was also observed, which indicates 
occurrence of ATP depletion.  
Conclusion: These findings demonstrate that excessive hepatic cholesterol induces 
blockage of autophagic flux, oxidative stress and the subsequent mitochondrial 
dysfunction. Although reduced autophagic activity per se was insufficient to cause 
cholesterol induced hepatocyte apoptosis entirely, it seems to aggravate oxidative stress 
due to attenuated removal of dysfunctional mitochondria. Overall, the present study 
demonstrates that cholesterol, besides free fatty acids, may contribute to lipotoxicity 
occurring in the progression of NAFLD.  
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1. Cholesterol-mediated lipotoxicity in NAFLD development 
1.1. Cholesterol metabolism in the liver 
Since hepatocytes are exposed to a great flux of cholesterol, unless cholesterol 
synthesis and uptake are counterbalanced by cholesterol removal, hepatic cholesterol 
accumulation occurs. Thus, balance among cholesterol de novo synthesis, uptake from 
all classes of plasma lipoprotein and efflux from hepatocytes is tightly regulated to 
maintain cholesterol levels within a specific range. Briefly, the synthesis of cholesterol 
occurs in the endoplasmic reticulum (ER) and is strictly regulated by the 3-hydroxy-3-
methyl-glutaryl-CoA reductase. The uptake of cholesterol from lipoproteins occurs 
through surface proteins, including low density lipoprotein receptor and scavenger 
receptor BI. Regardless of its origin, metabolic pathways of hepatic cholesterol are either 
efflux into the blood in the form of VLDL-C or through ATP-binding cassette 
transporters A1 to nascent HDL-C particles, excretion via ATP-binding cassette 
transporters G5/G8, deposition as cholesteryl ester, or substrate for bile acid synthesis 
(Ioannou, 2016). Multiple cholesterol metabolic and transport-related genes are involved 
in the highly orchestrated metabolic and trafficking pathways, under regulation of Sterol 
regulatory element-binding protein-2, liver X receptor ⍺ and farnesoid X receptor. 
Furthermore, within the hepatocyte, cholesterol must be sorted and localized in different 
regions and organelles. Different lipid composition among organelles are kept steady, 
for example, plasma membrane holds nearly 60 % of the cellular sterol, while the ER 
accounts for only 5 % (Mesmin et al., 2013). This unequal partition of sterol among 
organelles is important to exert normal cellular function. 
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1.2. Cholesterol accumulation and NAFLD 
Non-alcoholic fatty liver disease (NAFLD) is considered as fat deposition in the liver 
exceeding 5% by weight while <10g of daily alcohol is consumed (Byrne et al., 2009). 
The disease refers to a broad spectrum of liver disease encompassing simple steatosis, 
steatohepatitis, advanced fibrosis, and cirrhosis (Byrne et al., 2009). Though it is widely 
accepted that lipotoxicity plays a central role in development of NAFLD and the 
progression from simple steatosis to non-alcoholic steatohepatitis (NASH), the exact 
lipotoxic molecules have not been agreed on. To date, studies of molecular mechanism 
of NAFLD have mainly focused on triacylglycerol (TG) or free fatty acids, but a growing 
body of evidence suggests that an increased level of hepatic cholesterol is a leading 
factor in the development of the disease (Caballero et al., 2009; Mari et al., 2006; Min 
et al., 2012; Puri et al., 2007; Simonen et al., 2011; Van Rooyen et al., 2011). Extensive 
dysregulation of hepatic cholesterol homeostasis with increases in hepatic cholesterol 
level in NAFLD has been documented. Previous studies, which took lipidomic 
approaches to quantify the major lipid classes in the livers of NAFLD patients, have 
shown increases in hepatic cholesterol levels (Caballero et al., 2009; Puri et al., 2007). 
When wild-type rats were fed a choline-deficient or a hypercholesterolemia diet was fed, 
free cholesterol (FC), but not free fatty acids or TG, turned out to be responsible of 
inflammatory cytokines-mediated steatohepatitis through mitochondrial glutathione 
(GSH) depletion (Mari et al., 2006). The results were also confirmed in Niemann-Pick 
disease, type C1-defecient mice and obese ob/ob mice model (Mari et al., 2006). In 
another study, foz/foz mice were fed high-fat diets with varying percentages of 
cholesterol and displayed an increase in hepatic FC level. Hepatic FC level cove rrelated 
with histologic severity of NASH, while hepatic levels of TG, diacylglycerol, 
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monoacylglycerol, and free fatty acids remains unchanged in relation to the modulated 
severity of NASH despite their general elevation in high-fat fed foz/foz mice compared 
with wild-type counterparts (Van Rooyen et al., 2011). Based on a large body of data 
above, hepatic cholesterol could be considered as a possible underlying lipotoxic 




1.3. Mechanisms of cholesterol toxicity 
  Patients with metabolic disease or fatty liver express high level of TG, LDL-C, VLDL-
C and low level of HDL-C. Thus, cholesterol toxicity has been primarily studied in 
pancreatic β-cell since obesity is an important risk factor for type 2 diabetes. Cholesterol 
treatment induced insulin resistance, mitochondrial dysfunction, oxidative stress, and 
apoptosis in MIN6 cells, βTC3, 832/13 INS-1 insulinoma cells and primary pancreatic 
cell (Carrasco-Pozo et al., 2015; Hao et al., 2007; Lee et al., 2011; Simonen et al., 2011; 
Zhao et al., 2010). However, expression of glucose-regulated protein78 and CCAAT-
enhancer-binding protein homologous protein was not altered after cholesterol treatment 
in MIN6 cells (Simonen et al., 2011). Cholesterol toxicity was also investigated in depth 
in smooth muscle cells and macrophages, as they are the site of cardiovascular disease 
development. ER stress, destabilization of mitochondrial membrane permeability were 
commonly involved in toxic mechanism observed in smooth muscle cell (Kedi et al., 
2009; Rong et al., 2003; Xu et al., 2010). Interestingly, rapamycin treatment was 
reported to attenuate cholesterol-induced ER and mitochondrial stress (Xu et al., 2010). 
In macrophage, cholesterol treatment caused both Fas ligand activation and 
mitochondrial apoptosis represented by activation of caspase-9 and translocation of 
cytochrome C and bcl-2-associated X protein (Yao and Tabas, 2001). On the contrary, 
although growing evidence indicates that free cholesterol accumulation is seen in 
experimental and human NASH, direct impact of cholesterol on liver cells has been 
barely studied in vitro. Based on previous studies, Figure 1 depicts graphical abstract of 
possible toxic mechanisms induced by excess hepatic cholesterol. Activation of 
cholesterol de novo synthesis, increased cholesterol de-esterification, decreased 
cholesterol export and decreased bile acid synthesis are reported to contribute to 
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disruption of hepatic cholesterol homeostasis. Resulting accumulation of cholesterol is 
found to be in associated with the pathogenesis of NAFLD/NASH. FC accumulation 
activates intracellular signaling pathways in Kupffer cells and stellate cells, triggering 
inflammation and fibrogenesis. In hepatocytes, FC accumulation induces mitochondrial 
dysfunction, ER stress and ultimately apoptosis. Although ER stress and mitochondrial 
dysfunction are highlighted for their contribution in Figure 1, ER stress still remains 
controversial. An in vitro study using primary mouse hepatocyte incubated with LDL-C 
showed no alteration in CCAAT-enhancer-binding protein homologous protein and 
glucose-regulated protein78 protein level (Gan et al., 2014). Also, multiple experimental 
models showed that FC accumulation in mitochondria sensitized hepatocytes to tumor 
necrosis factor ⍺ leading to mitochondrial GSH depletion whereas FC distribution in ER 
and plasma membrane did not cause ER stress or alter tumor necrosis factor signaling 






Figure 1. Liver injury triggered by cholesterol accumulation  
(Arguello et al., 2015) ER, Endoplasmic reticulum; JNK, c-Jun N-terminal kinase; 
NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; ROS, 





2. Autophagy as a house keeping system 
2.1. The roles and the process of autophagy pathway  
Autophagy (Greek for “self-eating) is a process by which cytoplasmic materials 
including proteins, lipids, and even organelles, reach lysosomes for degradation 
(Mizushima et al., 2010). Three different types of autophagy are described: 
macroautophagy, chaperone-mediated autophagy and microautophagy. Of these 
classification, macroautophagy, herein simply referred to as autophagy, is the major form 
of autophagy and is conserved from yeast to mammals. This type of autophagy is 
mediated by a special vesicular organelle termed autophagosome. Chaperone-mediated 
autophagy requires chaperone proteins which facilitates direct translocation of cytosolic 
proteins across the lysosomal membrane. Microautophagy occurs through inward 
invagination of lysosomal membrane which enables delivery of a fraction of cytoplasm 
into the lysosomal lumen.  
Autophagy, as a major degradation system, exerts distinct functions such as turnover 
of bulky cellular constituents, maintenance of intracellular homeostasis, antigen 
presentation, and cell death (Cecconi and Levine, 2008; Deretic et al., 2013). Under 
basal conditions, cellular autophagic activity is usually kept at low, but can be sharply 
upregulated by numerous stimuli, such as starvation, hypoxia, energy depletion, ER 
stress, pharmacological agents, innate immune signals, and diseases such as bacterial, 
viral, and parasitic infections (Deretic et al., 2013; Mizushima et al., 2010). Conversely, 
autophagy suppression is often associated with certain disease, including cancers, 
neurodegenerative disorders, infectious diseases, and a decline in autophagy function is 
a hallmark of aging (Deretic et al., 2013; Mizushima et al., 2010). In an in vitro 
experiment using HeLa cells, when autophagy is pharmacologically inhibited by 3-
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methyladenine, chloroquine, bafilomycin A1, or monensin, the activation of caspase-3 
was observed, and nutrient depletion increased the level of the activation (Boya et al., 
2005).  
Autophagy proceeds through several stages in which specific regulatory proteins and 
complexes are required (Fig. 2). In the initiation or nucleation stage, isolation membrane, 
also called phagophore or preautophagosomal structure, is formed from preexisting 
plasma or organelle membranes. This stage requires the activation of UNC51-like kinase 
(ULK) complex and the class III phosphatidylinositol 3-kinase (PI3K) complex. ULK 
complex consists of ULK1/2, autophagy-related gene protein (Atg) 13, FAK family 
kinase interacting protein of 200 kDa and Atg101 (Kaur and Debnath, 2015). Class III 
PI3K complex is composed of vacuolar protein sorting34, along with its regulatory 
subunits Atg14L, vacuolar protein sorting15 and beclin1 (Kaur and Debnath, 2015). In 
the elongation stage, the Atg12-Atg5-Atg16L complex facilitates the addition of 
phosphatidylethanolamine group to the microtubule-associated protein 1 light chain 3 
(LC3). The LC3-II formed is then specifically associated with autophagosomes, and the 
phagosomal structure closes, enclosing a small portion of cytoplasm. Finally, the 
autophagosome fuses with lysosomes, leading to formation of the autolysosome. After 
fusion, delivered V+-ATPases and lysosomal hydrolases cause acidification and 




Figure 2. The process of macroautophagy 
(Deretic et al., 2013; Kaur and Debnath, 2015) Atg, autophagy related gene; LC3, 
microtubule-associated protein light chain 3; PE, phosphatidylethanolamine; PI3K, 




2.2. Markers for monitoring autophagy 
In mammalian cells, most of the Atg proteins, for example, ULK1/2, Atg13, FIP200, 
Atg101, Beclin 1, Atg14, LC3, Atg12, Atg16L, are observed on isolation membranes 
but not on complete autophagosomes (Longatti and Tooze, 2009). Only LC3, a 
mammalian homolog of yeast Atg8, is known to exist on autophaogomes, which makes 
this protein serve as a widely used marker for autophagosomes. However, the level of 
LC3 protein should be interpreted with caution because autophagosome accumulation 
may represent either autophagy induction or, oppositely, suppression of later steps in the 
autophagy pathway after autophagosome formation, given that the autophagosome is a 
mere intermediate structure in a dynamic pathway. Under normal conditions, basal 
autophagy occurs and when autophagy is induced, all types of autophagic structures, 
such as isolation membrane, autophagosome, and autolysosome, increase. When 
autophagy is suppressed at any step upstream, none of the autophagic structures are 
generated. When autophagy is suppressed at any step after complete closure of the 
autophagosome, only autophagosomes accumulate. Thus, the simple determination of 
numbers of autophagosomes is not sufficient to estimate autophagic activity. Rather, 
measuring autophagic flux is a more reliable indicator of autophagic activity. Autophagic 
flux encompasses the comprehensive process of autophagy from autophagosome 
synthesis to degradation of autophagic substrates inside the lysosome. One of the 
principal methods to measure autophagic flux is monitoring of LC3 turnover, which is 
based on the fact that LC3-II is degraded in autolysosomes. Treating cells with lysosomal 
inhibitors such as ammonium chloride, chloroquine, or bafilomycin A1, which inhibit 
acidification inside the lysosome or autophagosome-lysosome fusion or with inhibitors 






Figure 3. Interpretation of LC3 immunoblotting. 






3). Therefore, net amount of degradation, or autophagic flux can be estimated by 
measuring the differences in the amount of LC3-II between samples in the presence and 
absence of lysosomal inhibitors. The difference in the levels of LC3-II in the presence 
or absence of lysosomal inhibitor reflects the net amount of this protein delivered to the 
lysosomes. If a compound raises LC3-II levels in the absence of inhibitor, but there is no 
further rise in its presence, then it can be inferred that there is a blockage in LC3-II 
degradation (Rios-Marco et al., 2015; Rubinsztein et al., 2009). The p62 protein, also 
known as sequestome1, can also be used to monitor autophagic flux. The p62 protein 
serves as a link between LC3 and ubiquitinated substrates and is efficiently degraded by 
autophagy. Thus, decreased autophagic flux correlates with an increased p62 level, and 
vice versa, increased autophagic flux correlates with a decreased p62 level (Zhang et al., 
2013). However, unlike LC3, p62 has some potential experimental pitfalls by nature. 
P62 can be also degraded by ubiquitin-proteasome system and can interact with several 
other signaling molecules other than LC3 (Moscat and Diaz-Meco, 2009). Also, it can 
be transcriptionally upregulated under certain conditions (Nakaso et al., 2004). Thus, 
measurement of the p62 level is recommended to be performed along with other methods 
such as LC3-II turnover assay (Zhang et al., 2013).   
Currently, it is not clear whether autophagic activity per se can be transcriptionally 
regulated or not. Thus, mRNA levels of LC3 and other autophagy genes are not 
recommended to measure autophagic activity, although they may be transcriptionally 
upregulated in response to stress conditions that induce autophagy. In fact, Atg proteins 
are constitutively expressed in sufficient amounts, so their posttranslational 
modifications and/or associations with other members of the autophagic machinery are 
considered more important indicators of autophagic activity (Mizushima et al., 2010).  
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Lastly, although the number and activity of lysosomes are commonly used as markers 
for autophagic activity, they are not a reliable general indicator of autophagy in 
mammalian cells. They may work well in Drosphila, but for mammalian cells, the use 
of LysoTracker, acridine orange or monodansylcadaverine is not recommended 




3. Aims of the study 
Given the strong association between NAFLD progression and hepatic cholesterol 
accumulation, cholesterol may be a possible lipotoxic molecule leading to NAFLD. Thus, 
this study was conducted to determine cholesterol lipotoxicity in hepatocytes using 
cholesterol overloaded HepG2 cells. Precisely, whether dysregulated cholesterol 





Ⅱ. Materials and Methods 
 
1. Cell culture 
A human, well differentiated hepatoblastoma cell line, HepG2 cells chosen in this 
study have been shown to retain a wide variety of liver-specific metabolic functions 
including cholesterol and triglyceride metabolism (Javitt, 1990; Molowa and Cimis, 
1989). HepG2 cells were obtained from American Type Culture Collection (ATCC, USA) 
and were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Welgene Biotech, 
South Korea) supplemented with 10% heat inactivated fetal bovine serum (Welgene 
Biotech, South Korea), 1% penicillin-streptomycin (Welgene Biotech, South Korea). 
Cell cultures were maintained in a humidified incubator in 5% CO2 atmosphere at 37 °C. 
 
2. Cholesterol overloading 
 Cholesterol was delivered to HepG2 cells by cholesterol:methyl-β-cyclodextrin 
complex which contains approximately 45 mg of cholesterol/g (Sigma, USA). 
Cyclodextrins are water soluble cyclic oligosaccharides consisting of α-(1-4)-linked D-
glycopyranose units, which contain a hydrophobic cavity capable of encapsulating 
hydrophobic molecules, in this case, cholesterol (Zidovetzki and Levitan, 2007). 
Cholesterol:methyl-β-cyclodextrin has been frequently chosen to manipulate the 
cholesterol contents within cells (Christian et al., 1997; Garbarino et al., 2012; Rong et 
al., 2003; Vengrenyuk et al., 2015; Wang et al., 2015; Xu et al., 2010). 
Cholesterol:methyl-β-cyclodextrin stock was prepared by dissolving the powder in water. 
HepG2 cells were plated on the culture dish until the cells reached 70-80% confluence 
and the serum in media was deprived for 12 h. To load excess cholesterol, the monolayer 
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was incubated with 25 or 50 µg/mL cholesterol in the culture media for 24 h. All 
treatment concentrations indicated were calculated based on cholesterol weight. Same 
volume of water loaded cells as cholesterol treated cells were used as vehicle control. 
 
3. Light microscopy 
 HepG2 cells were equally seeded in 96-well plate (Corning Inc., USA) and then treated 
with cholesterol for 12 h. The cells were washed gently three times with phosphate 
buffered saline (PBS). The morphology of HepG2 cells was observed under light 
microscope (Olympus CKX41, Japan). 
 
4. Total cholesterol mass quantification 
Cellular total cholesterol (TC) was quantitated by a modification of previously 
described methods. Briefly, cells were harvest in PBS and sonicated. The protein content 
of the homogenate was measured using a protein assay kit (Bio-Rad, USA). 300 µL 
homogenate containing 1 mg/mL protein was prepared, mixed with 1.2 mL of 
chloroform/methanol (2:1, v:v), and incubated overnight at 4°C. Thereafter, 240 µL of 
0.88% KCl was added for aggregation of non-lipid contents and centrifuged at 1000×g 
for 15 min at 4°C. The bottom layer was obtained, aliquoted. The solvent was then 
evaporated from aliquots, and the lipid residue was solubilized in the assay buffer in the 
same volume evaporated. The amount of TC was determined by enzymatic colorimetric 
methods using the commercial kits according to the manufacturer's instructions (Asan 
Pharmaceutical Co, South Korea). Cellular cholesterol results are reported as µg of TC 




5. Lipid peroxidation measurement 
 Lipid peroxidation was determined by measuring thiobarbituric acid reactive 
substances (TBARS) in HepG2 cells as described by Ohkawa et al (Ohkawa et al., 1979). 
Briefly, cells were collected in homogenizing buffer [Homogenizing buffer; 154 mM 
KCl, 50 mM Tris-HCl, 1mM EDTA (pH7.4)] and lysed by sonication. Resultant whole 
cell lysates were mixed with 8.1% SDS, 10% acetic acid, 0.8% thiobarbituric acid (TBA) 
followed by 1 h incubation in a 95℃ water bath. After development of the color, tubes 
were immediately cooled on ice for termination of the reaction. 1-butanol:pyridine 
mixture (15:1, v/v) was then added, vortexed vigorously and centrifuged at 4000 rpm for 
20 mins to obtain supernatant. The absorbance of the supernatant was measured at 532 
nm using UV-visible Spectrophotometer (Molecular Device, USA). Absorbance 
readings at 532nm were converted to TBARS values (nmol/mg protein), using 1,1,3,3-
tetraethoxypropane as a reference standard. 
 
6. Detection of Reactive Oxygen Species Generation 
 Oxidation of 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA; Sigma, USA) 
occurs almost exclusively in the cytosol, and generates a fluorescence that is proportional 
to reactive oxygen species (ROS) generation. Thus, the presence of ROS was measured 
using the probe. Briefly, HepG2 cells were cultured in phenol red free DMEM with 10% 
FBS in Lab-TEK TekII chamber slides (Fisher Scientific, USA) and after reaching 60-
70% confluency, cells were treated with either 50 μM H2O2 or 50 μg/mL cholesterol in 
phenol red free, serum free DMEM for 24 h. After treatments, cells were washed twice 
with PBS and incubated with 25 µM of H2DCFDA dye for 30 min at 37°C in dark. 
Following incubations, cells were washed once with PBS and immediately examined 
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under Axio Observer Z.1 inverted light microscope (Carl Zeiss, Germany) equipped with 
fluorescein isothiocyanate filter. Fluorescent photos were taken once per well due to the 
photosensitivity of the H2DCFDA reagent observed under fluorescent wavelengths. 
 
7. Cell viability determination 
Cell viability was quantified using a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) assay by measuring mitochondrial dehydrogenase activity. 
The assay is based on the ability of living cells to convert water-soluble MTT into 
insoluble purple formazan that is proportional to the number of respiring cells. HepG2 
cells were seeded at the density of 5×105 cells/well in a 96-well plate and allowed to 
attach for 24 h. After treatments, cells were incubated with final concentration of 0.5 
mg/mL of MTT in DMEM for 1 h at 37°C. The media was then aspirated with little 
disturbance of the formazan crystals, which were later solubilized in DMSO for a further 
1h before measuring the optical density. The absorbance was read at 540 and 690 nm in 
a microplate reader (Bio-Rad, USA). The corrected absorbance was obtained by 
subtracting the 690 nm value from the 540 nm value for background correction, 
eliminating unspecific signal. Relative cell viability was calculated as percentage of 
control.  
 
8. Total protein extraction 
Unless otherwise noted, after treatment, cells were rinsed with ice cold PBS and lysed 
in the ice-cold lysis buffer containing 50 mM Hepes-KOH (pH 7.5), 150 mM NaCl, 1 
mM EDTA (pH 8.0), 2.5 mM EGTA (pH 8.0), 1mM NaF, 10mM β-glycerophosphate, 
0.1 mM Na3VO4, 1 mM DTT, 0.1% Tween-20, 10% glycerol, protease inhibitor cocktail 
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(Sigma, USA). Lysates were centrifuged at 10000×g for 30 min at 4°C. Supernatant 
containing protein content was collected and measured using protein assay kit (Bio-Rad, 
USA). 
 
9. Protein solubility fractionation 
Detergent insoluble fraction was collected as previously described (Park et al., 2014) 
with little variation. Briefly, cells were lysed in a lysis buffer containing 0.1% Triton X-
100 instead of 0.1% Tween-20. Cell lysates were centrifuged at 15,000 r.p.m for 15 min 
at 4°C to obtain supernatants. Pellets were resuspended in a lysis buffer containing 1% 
Triton X-100, the procedure being repeated. Lastly, detergent insoluble pellets were 
solubilized in a lysis buffer containing 2% SDS. 
 
10. Western blotting 
For immunoblotting, equal amounts of protein were boiled in SDS sample buffer for 
5 min, loaded into the lanes of SDS-PAGE gel, separated and then transferred to 
polyvinylidene fluoride membrane. After blocking, with either 5% non-fat milk or 5% 
BSA, membranes were probed with specific primary antibodies and subsequently 
incubated with HRP-linked secondary antibodies. The immunoreactive protein bands 
were visualized by chemiluminescent using HRP substrate (Millipore, USA) with 
exposure to X-ray film (Fuji, Japan). The bands intensities were quantified with the 
Quantity one software (Bio-Rad, USA). Primary antibodies were obtained as followings; 
(nonerythroid) α-spectrin (Chemicon, USA), Ub (Santa Cruz Biotechnology, USA), 
Beclin-1 (Santa Cruz Biotechnology, USA), Caspase-3 (Cell Signaling, USA),  KDEL 
(Enzo Life Sciences, USA), LC3 (Novus Biology, USA), p-JNK (Cell Signaling, USA), 
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JNK (Cell Signaling, USA), p62 (Santa Cruz Biotechnology, USA), Caspase-9 (Cell 
Signaling, USA), p-AMPK (Cell Signaling, USA), AMPK (Cell Signaling, USA). 
 
11. Statistical analysis  
All data were analyzed using SPSS software (ver. 22.0, SPSS Inc., USA). The data 
were analyzed by one-way analysis of variance (ANOVA). Where appropriate, post hoc 
comparisons were made by Duncan’s multiple range test. Student’s t-test was used for 
two-group comparison. The data were reported as means ± SEM, and differences were 







1. Incubation with cholesterol increases cellular cholesterol content in 
HepG2 cells 
 Cells were exposed to the indicated concentrations of cholesterol for 24h and the 
cellular lipid content was measured (Fig. 4). As a result, incubation with 50 µg/mL 
cholesterol raised intracellular cholesterol level compared with control cells.  
 In a human study (Puri et al., 2007), hepatic FC level of control group was reported to 
be approximately 20 µg/mg protein, and this value increased by 1.7-fold in the NASH 
group. Another previous study (Wouters et al., 2008) using LDLR−/− male mice, which 
bear many characteristics of human NAFLD/NASH, showed that liver TC levels reached 
approximately 80 µg/mg protein with signs of hepatic inflammation after 7 days of a 
high-fat, high-cholesterol diets. Hepatic TC levels of chow diet group in this study was 
approximately 30 µg/mg protein and no increase in liver TG levels was shown. Thus, 
measured quantity of accumulated cholesterol seems to be physiologically relevant to 






Figure 4. Intracellular lipid contents after cholesterol treatment in HepG2 cells 
Cells were incubated with the indicated concentration of cholesterol in media without 
serum for 24 h and intracellular total cholesterol. Bars represent the means ± SEM (n = 





2. Cholesterol overloading suppresses cell viability and induces apoptosis 
in HepG2 cells 
 Previous studies reported cholesterol induced cytotoxity in several cell types. Thus, to 
determine whether cholesterol reduces cell viability in hepatocytes, HepG2 cells were 
exposed to the indicated concentrations of cholesterol and the cell viability was 
measured by MTT assays. As a result, dose-dependent reduction of cell viability was 
observed after 24 h. Cell population decreased following the incubation in cholesterol 
(Fig.5, Fig.6). Non-erythroid spectrin (also called fodrin) is a major component of 
cortical cytoskeleton that has binding sites for several proteins, and it consists of α and 
β subunits (Cryns et al., 1996). Proteolysis of fodrin has been detected during apoptosis 
of various cell lines and inhibited under conditions where apoptosis was prevented. 
Previous study (Martin et al., 1995) suggested that given its role as a major component 
of the plasma membrane-associated cytoskeleton, membrane blebbing in apoptosis may 
be at least partly due to disruption of the fodrin network. Thus, to confirm occurrence of 
apoptosis, HepG2 cells were exposed to the cholesterol for 24h and the cleavage of α-
fodrin was determined by Western blotting. Decreases in the intact form (280kDa) of 
non-erythroid spectrin by cholesterol was observed (Fig.7A). Cleaved caspase-3, an 
effector molecule commonly involved in apoptosis, was also increased as dose of 




Figure 5. Effects of cholesterol on cell viability in HepG2 cells 
Cells were incubated with the indicated concentration of cholesterol in media without 
serum and the cell viability was measured by MTT assay. Bars represent the means ±  





Figure 6. Effects of cholesterol on cell populations in HepG2 cells  
The microscopic images of HepG2 cells after treatment of cholesterol for 24 h were 
photographed. The cellular population was observed using inverted light microscopy. 











Figure 7. Effects of cholesterol on apoptosis in HepG2 cells 
α-Spectrin and cleaved caspase-3 were detected by immunoblotting and quantitated. 
Cells were treated with 25 µg/mL or 50 µg/mL cholesterol in media without serum for 
24 h after serum deprived overnight. The total protein lysates were subjected to SDS-
PAGE and transferred to PVDF membrane. (A) Representative α-spectrin and β-actin 
immunoblots are shown. The ratio of intact spectrin and SBDPs are expressed as 
percentage of the control value. Each bar represents means ± SEM (n = 6). (A) 
Representative cleaved caspase-3 and β-actin immunoblots are shown. The ratio of 
cleaved caspase-3 is expressed as percentage of the control value. Each bar represents 





3. Cholesterol overloading results in increases of autophagic markers in 
HepG2 cells 
Autophagy is regulated by autophagy specific genes (Atg) including Beclin1, the 
mammalian orthologue of Atg6 in yeast. Beclin 1 localizes to the trans-Golgi network, 
belongs to the class III PI3K complex and participates in autophagosome formation. LC3, 
mammalian homolog of yeast Atg8, exists in two forms: cytosolic-associated LC3-I and 
membrane-bound LC3-II which is a proteolytic derivative of the former (16 and 14 kDa, 
respectively). LC3-II can be used to estimate the abundance of autophagosomes before 
they are destroyed through fusion with lysosomes (Boya et al., 2005). Adaptor protein 
p62 binds to LC3 and facilitates the autophagic degradation of ubiquitinated protein 
aggregates in lysosomes. Both p62 and LC3 are routinely used as biomarkers to monitor 
the level of autophagy. 
Previous study reported that autophagy showed a protective effect against FC overload-
induced death in smooth muscle cell (Xu et al., 2010). To determine whether autophagy 
is activated by cholesterol treatment in HepG2, autophagy markers aforementioned were 
detected (Fig.8). Treatment of cholesterol strongly induced the increase of LC3-II and 















Figure 8. Effects of cholesterol on autophagic in HepG2 cells. 
Relative expression of autophagic markers were detected by immunoblotting and 
quantitated. Cells were treated with 25 µg/mL or 50 µg/mL cholesterol in media without 
serum for 24 h after serum deprived overnight. (A) Representative LC3 immunoblots 
are shown. Relative expression of LC3-II was quantified and expressed as percentage 
over the control value. Each bar represents means ± SEM (n = 6). (B) Representative 
Beclin-1 immunoblots are shown. Relative expression of Beclin-1 was quantified and 
expressed as percentage over the control value. Each bar represents means ± SEM (n = 
5). (C) Representative p62 immunoblots are shown. Relative expression of p62 was 
quantified and expressed as percentage over the control value. Each bar represents means 





4. Autophagic flux is reduced in cholesterol overloaded HepG2 cells. 
 Cholesterol overloading increased LC3-II and p62 protein levels as shown in Fig.8. 
Since increased p62 protein level correlates decreased autophagic flux (Zhang et al., 
2013), LC3-II level was measured in the presence/absence of lysosomal inhibitor 
chloroquine (Fig. 9A). Lysosomal lumen alkalizer chloroquine is frequently employed 
to investigate autophagic flux by block autophagic progress by impairing lysosomes. 
Figure 9B illustrates that cholesterol treatment for 24 h indeed lowered the net amount 
of LC3-II delivered to the lysosomes.  
  To determine the functional importance of autophagy inhibition and lysosomal 
impairment in HepG2 cells, ubiquitinated proteins and p62 proteins were measured. The 
two main intracellular protein degrading systems, ubiquitin-proteasome and autophagy-
lysosome pathways, are closely engaged. It is well known that ubiquitinated proteins 
target p62 for autophagic degradation, and disruption of the autophagy-lysosome 
pathway results in ubiquitinated aggregates (Korolchuk et al., 2009; Yu et al., 2013). 
Compared to control group, levels of p62 and ubiquitinated proteins increased after 
exposure to cholesterol for 24 h. Moreover, further autophagy inhibition increased levels 








Figure 9. Cholesterol-induced reduction in autophagic flux in HepG2 cells  
Cells were treated with 50 µg/mL cholesterol in the presence or the absence of 10 µM 
chloroquine in media without serum for 24 h after serum deprived overnight. PBS 
treatment was used as the vehicle control. (A) Representative LC3 immunoblots of four 
independent experiments are shown. (B) Effect of cholesterol on the autophagic flux in 
HepG2 is displayed as a diagram. Autophagic flux was determined by the strength of 
LC3-II accumulation in a 24 h treatment period with chloroquine. Therefore, normalized 
LC3-II levels in the absence of chloroquine were subtracted from the corresponding 
levels obtained in the presence of chloroquine. Values are expressed as means ± SEM (n 
= 4) and asterisk indicates statistical significance. (C) Representative ubiquitinated 
proteins and p62 immunoblots of four independent experiments are shown. 
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5. Attenuation of autophagic flux by cholesterol is insufficient to trigger 
systemic cell death in HepG2 cells. 
 Autophagy inhibition is known to induce caspase-3 activation and ultimately apoptosis 
(Boya et al., 2005). As observed in Figure 9, 10 µM chloroquine treatment resulted in 
similar quantity of LC3-II, p62 and ubiquitinated protein accumulation as 50 µg/mL 
cholesterol treatment. Thus, cell viability level was compared between the two 
treatments to measure to what extent blockage of autophagic flux contributes to 
cholesterol induced caspase-3 activation (Fig. 10). As a result, 10 µM chloroquine 
treatment had little impact on cell viability level, from which can be inferred that 
blockage of autophagic flux is not enough to cause systemic cell death, unless other toxic 






Figure 10. Effects of autophagy inhibition on cell viability in HepG2 cells. 
Cells were incubated with 50 µg/mL cholesterol in the presence or the absence of 10 µM 
chloroquine in media without serum for 24 h after serum deprived overnight. PBS 
treatment was used as the vehicle control. The cell viability was measured by MTT assay. 
Bars represent the means ± SEM (n = 3) and bars with different superscripts are 




6. Cholesterol overloading produces intracellular ROS and induces lipid 
peroxidation in HepG2 cells   
 ROS plays a key role in cell apoptosis. Therefore, generation of intracellular ROS by 
DCF, which is a probe oxidized by ROS to produce green fluorescence. Figure 11A 
shows that a significant increase in the ROS level (green fluorescence) appeared in cells 
treated with 50 µg/mL cholesterol for 24 h when compared with the control cells and 
even with positive control cells treated with 50 µM H2O2. In addition, as seen in the 
Figure 11B, cholesterol promoted production of lipid peroxidation. Previous studies 
have identified c-Jun N-terminal kinase (JNK) overactivation as an underlying 
mechanism of hepatocyte death from oxidant stress (Wang et al., 2004; Wang et al., 
2010). Therefore, we determined the activation of JNK and observed an increase in 
















Figure 11. Effects of cholesterol on oxidative stress of HepG2 cells 
(A) Either 50 µg/mL cholesterol or 50 µM H2O2 was treated for 24 h and intracellular 
ROS level was detected by observing Oxidation of H2DCFDA. Representative of three 
brightfield (BF), H2DCFDA (DCF) images from exact same time point are shown. (B) 
Cells were treated with 25 µg/mL or 50 µg/mL cholesterol in media without serum for 
24 h after serum deprived overnight and lipid peroxidation was determined by measuring 
TBARS. Each bar represents the means ± SEM (n = 3). (C) Representative p-JNK 
immunoblots are shown. Relative expression of p-JNK was quantified and expressed as 
percentage over the control value. Each bar represents means ± SEM (n = 8). Bars with 




7. Defective mitochondria is involved in cholesterol-induced cell death in 
HepG2 cells 
 Because hepatocyte free cholesterol lipotoxicity caused by JNK1-mediated 
mitochondrial injury (Gan et al., 2014), we determined parameters of mitochondria 
toxicity. Following mitochondrial outer membrane permeabilization, various proteins 
are released from the mitochondrial intermembrane space and promote caspase 
activation and apoptosis. Cytochrome c binds apoptotic protease-activation factor 1, 
inducing its oligomerization and thereby forming apoptosome that recruits and activates 
an initiator caspase 9. Caspase 9 cleaves and activates executioner caspase 3 and caspase 
7, leading to apoptosis (Tait and Green, 2010). Thus, cleavage of caspase 9 was detected 
to confirm mitochondrial damage. Mitochondrial damage results in insufficient 
production of ATP, leading to the activation of adenosine monophosphate-activated 
kinase (AMPK). Reduction of the ATP levels have severe consequences to the cell’s 
function and health, since ATP mediates signal transduction, metabolism, active 
transport, DNA and RNA synthesis, and other critical pathways. Thus, phosphorylation 
status of Thr172 of AMPK was analyzed to indirectly investigate cellular ATP level. The 








Figure 12. Effects of cholesterol on mitochondria in HepG2 cells 
Cells were treated with 25 µg/mL or 50 µg/mL cholesterol in media without serum for 
24 h after serum deprived overnight. (A) Representative cleaved caspase-9 immunoblots 
are shown. Relative expression of cleaved caspase-9 was quantified and expressed as 
percentage over the control value. Each bar represents means ± SEM (n = 4). (B) 
Representative p-AMPK immunoblots are shown. Relative expression of p-AMPK was 
quantified and expressed as percentage over the control value. Each bar represents means 







 Lipotoxicity links ectopic lipid accumulation and cell death, and has been thought to 
be the main contributor to the progression of various diseases, such as obesity, diabetes, 
and NAFLD (Brookheart et al., 2009). On the other hand, autophagy is essential for 
maintaining cellular homeostasis by preventing accumulation of damaged proteins and 
organelles. In this study, we examined whether cholesterol plays a role in hepatocyte 
lipotoxicity in relation to NAFLD pathology. For the first time, effects of hepatic 
cholesterol accumulation on the autophagic process were examined. Previously, there 
have been reports which investigated the toxic effects of cholesterol and its leading role 
on NAFLD development in vivo. However, tools to measure autophagic flux in vivo 
have been limited. Thus, no data is available despite compelling associations between 
cholesterol and pathological phenotype of NAFLD in terms of autophagy. 
 Herein, cholesterol treatment resulted in increases in LC3-II and p62 protein levels and 
concomitant increases in ubiquitinated proteins in HepG2 cells. Given that decreased 
autophagic flux correlates with an increased p62 level and vice versa (Zhang et al., 2013), 
accumulation of LC3-II protein was suspected to be the results of decreased 
autophagosome clearance. This was confirmed by further investigations of autophagy 
pathway under cholesterol accumulation using a lysosomotropic agent chloroquine. 
LC3-II turnover assay using chloroquine revealed that autophagic flux was indeed 
reduced after cholesterol overloading. Consistently, associations between steatotic liver 
and defective autophagy have been reported in several studies. Accumulation of p62 
proteins in cholesterol loaded HepG2 cells matches with the previous reports. For 
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instances, p62 protein was accumulated in the liver of Ob/Ob mice, implying deficiency 
in autophagic degradation in steatotic livers (Inami et al., 2011). In NAFLD patients, 
p62 aggregation was correlated with serum alanine aminotransferase value and 
inflammatory activity by NAFLD score (Fukuo et al., 2014). Therefore, in align with 
these previous reports, the present study suggests that cholesterol may be one of the 
causes of perturbation of autophagy in fatty liver. Accumulation of ubiquitinated proteins 
after cholesterol loading in our experiments can be understood as a result of attenuated 
autophagic flux as well, as it conforms with a previous study which demonstrated that 
liver-specific Atg7 knock-out mice display liver dysfunction with intracellular 
accumulation of ubiquitinated protein aggregates (Komatsu et al., 2005). Our study lacks 
analysis of protein markers that can serve to indicate autophagy induction, such as 
conjugation product of cleaved Atg5 with Atg12. Atg12-Atg5 forms a complex with 
Atg16L1 that is essential for autophagosome formation. Thus, in our study, only limited 
interpretation was made to determine whether cholesterol induced autophgosome 
formation. The level of autophagosome synthesis can be inferred by subtracting 
normalized LC3-II levels in the absence of cholesterol from the corresponding levels 
obtained in the presence of cholesterol, under CQ treatment (Fig.  3). This result 
indicates that cholesterol treatment induced small amount of autophagosome formation. 
Further detection of autophagy markers would be needed for more accurate 
interpretation. 
 In MTT assays, we observed that there were no additive reduction of cell viability when 
cells were treated with cholesterol and chloroquine at the same time. This finding implies 
that cholesterol per se has inhibited comparable degradation of autophagosomes to 
chloroquine. Also, it can be inferred that blockage of autophagic flux by chloroquine 
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treatment alone, without any disturbances in cellular homeostatic state, has only minor 
impacts on cell death. Although pharmacological or genetical inhibition of autophagy is 
enough to activate apoptosis (Boya et al., 2005), our finding indicates that autophagy is 
important in cell survival in that it mitigates cytotoxicity when cellular homeostasis is 
disturbed, in this case cholesterol accumulation. 
 Yet, the mechanism of blunt autophagic activity under cholesterol loading remains 
unclear. Decreases in autophagic pathway proteins have been reported after lipid stress 
(Liu et al., 2009; Yang et al., 2010). Other mechanisms reported include reduced levels 
of cellular ATP (Las et al., 2011), lysosomal membrane permeabilization and reduced 
levels of lysosomal enzymes (Inami et al., 2011). One study reported that altered 
cholesterol level of autophagosomes and lysosomal membrane results in defects in the 
process of autophagosome-lysosome fusion, emphasizing the effects of changes in lipid 
metabolism and intracellular lipid content on autophagy (Koga et al., 2010). Cholesterol 
is well known to pack tightly between saturated fatty acyl groups of membrane 
phospholipids, decreasing membrane fluidity (Ioannou, 2016). Meanwhile, excess 
cholesterol distributes to mitochondria, plasma membrane and ER in livers from diabetes 
and metabolic syndrome-related experimental NASH and in LDL-incubated primary 
hepatocytes (Gan et al., 2014). Therefore, considering that the origin of autophagosome 
membrane is the preexisting cellular membrane (Carlsson and Simonsen, 2015), altered 
membrane cholesterol content seems to be the most prominent explanation for the 
reduced autophagic clearance. The fact that lipid droplet size and fusion between 
droplets are affected by the FC contained in phospholipid monolayer membrane of lipid 
droplets (Thiam et al., 2013), further supports a possible direct regulatory effect of 
cholesterol on fusogenic capabilities. At this time, although the underlying mechanism 
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of lowered autophagic flux may be multifactorial, the important implication here is that 
dysfunction of the autophagy pathway has been linked to a variety of diseases. For 
instance, harmful cycle may exist in which independent factors promote both impaired 
autophagy and hepatic steatosis. The decrease in autophagy may aggravate steatosis, 
which would further impair autophagy. This cycle would worsen both cellular 
autophagic function and lipid accumulation perpetually (Czaja et al., 2013). Critical 
function for autophagy in lipid metabolism is already well-established. Previous study 
investigated consequences of a genetic blockage of autophagy by siATG5 on intracellular 
lipid content. When cells were incubated with oleate under autophagy inhibition, the 
level of TG significantly increased. Moreover, when cholesterol was further added, the 
level of intracellular cholesterol also showed significant increase compared to cells 
bearing normal autophagy function (Singh et al., 2009).   
 The cholesterol in membranes affects the function of many transmembrane proteins. In 
particular, increased mitochondrial FC reduces mitochondrial membrane fluidity and 
impairs the function of mitochondrial GSH transporter, thereby promoting mitochondrial 
ROS generation, lipid peroxidation, and finally resulting in hepatocyte necrosis and 
apoptosis (Ioannou, 2016). NAD(P)H oxidase is another protein reported to be affected 
by membrane lipid raft. Given the fact that cholesterol accumulation in the plasma 
membrane promotes formation of membrane lipid raft (Gaus et al., 2003) and lipid rafts 
are implicated in aggregation and activation of NAD(P)H oxidase (Zhang et al., 2006), 
it is possible that cholesterol loading activates NAD(P)H oxidase and generates ROS. In 
the present study, increased production of intracellular ROS confirmed by DCF 
fluorescence images and increased level of lipid peroxides. Consistently, inhibition of 
autophagy by 3-methyladenine exacerbated death of cells exposed to 4-hydroxynonenal, 
 
44 
a lipid peroxidation product in vascular smooth muscle cells (Hill et al., 2008). In animal 
model of autophagy disruption, isolated mitochondria from Atg7-deficient skeletal 
muscle and pancreatic beta cells exhibited a significant mitochondrial dysfunction and 
oxidative stress, which resulted in the physiological impairment in glucose metabolism 
(Wu et al., 2009). Furthermore, a previous study reported that FC loading, but not free 
fatty acid or triglyceride loading, increased susceptibility to tumor necrosis factor-
induced hepatotoxicity by depleting mitochondrial GSH (Mari et al., 2006). Therefore, 
these results suggest that mitochondrial FC may induce NAFLD by disturbing the 
mitochondrial antioxidant system, which is required for hepatocytes to resist oxidative 
stress induced cell death. Previous studies have identified that JNK overactivation is an 
underlying mechanism of hepatocyte death from oxidant stress (Wang et al., 2004; Wang 
et al., 2010). Consistently, we observed an increase in phosphorylated form of JNK by 
cholesterol, suggesting that overactivation of the JNK may play a pivotal role in 
hepatocyte death from cholesterol-induced oxidative stress. 
 Autophagy is essential for maintaining cellular homeostasis by removing aggregated 
and misfolded-protein and damaged cellular organelles, such as mitochondria and ER 
(Mortensen et al., 2010; Yang et al., 2010). Therefore, accumulation of damaged 
organelles under defective autophagy may have further exacerbated toxic effects. We 
observed an increase in phosphorylated AMPK proteins and cleaved caspase-9 proteins 
which implies ATP depletion and mitochondrial damage.   
 In conclusion, the present study showed that cholesterol accumulation leads to 
decreases in autophagic flux and increases in oxidative stress in HepG2 cells. Reduced 
autophagic activity seems to aggravate oxidative stress due to attenuated removal of 
dysfunctional mitochondria. Cholesterol also activates JNK signaling pathway that may 
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have induced ATP depletion and caspase cleavage. Thus, disturbed autophagy induced 
by cholesterol overloading may have sensitized cells to apoptotic death from 
mitochondrial damage due to oxidative stress. The present study showed that cholesterol, 
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HepG2 세포주에서 콜레스테롤에 의한 
자가포식과 세포 사멸 연구 
 
 
서울대학교 대학원 식품영양학과 
김소라 
 
비알콜성 지방간질환(NAFLD)은 전세계적으로 비만과 제2형 당뇨병이 
증가하면서 그 유병률이 크게 증가하고 있으며 바이러스, 알코올, 약물, 
유전에 의한 간질환을 제외하고, 원인을 모르는 간질환의 90%를 차지하는 
가장 흔한 만성 질환이다. 최근 다수의 연구에서 이 비알콜성 지방간질환의 
발병 시 간에 과다한 콜레스테롤이 축적됨을 보고하고 있으므로 
콜레스테롤은 간에 독성을 일으키는 지질대사물로 주목 받고 있다. 
자가포식은 세포의 방어기전으로 세포에 가해지는 스트레스 상황에서 
대사물질을 제공하는 적응 반응인 동시에 유해 물질 및 단백질, 지질, 
소기관을 포함한 물질들을 분해하여 항상성을 유지하는 기전이다. 이러한 
맥락에서 본 연구는 간세포에 과다하게 축적된 콜레스테롤이 세포 독성을 
일으키는지 확인하고자 하였으며 세포 내 콜레스테롤 항상성이 깨진 
스트레스 상황에서 자가포식의 활성에 변화가 생기는지, 또 변화된 
자가포식 기전이 콜레스테롤에 의한 세포 독성에 기여하는 지 확인하고자 
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하였다. 간세포에 축적된 콜레스테롤의 독성과 이 스트레스 환경에서 
자가포식 기전의 역할을 살펴보기 위하여 인간 간암 세포주인 HepG2 
세포주가 배양되는 배지에 25 혹은 50 µg/mL 농도의 콜레스테롤을 녹여 
처리하였다. 사용된 콜레스테롤의 농도는 비알콜성 지방간염 환자의 간이나 
실험 동물의 간에서 확인된 콜레스테롤 축적 양과 비슷한 세포 내 축적을 
일으켰다. 콜레스테롤을 24시간 처리하자 세포 내 총콜레스테롤의 양이 50 
µg/mL 농도의 콜레스테롤 처리 시 대조군에 비해 유의적으로 증가하였다. 
MTT assay, 현미경 관찰을 통해 콜레스테롤 처리 시 세포 생존율이 
감소하는 것을 확인하였으며 Western blotting을 통한 spectrin 단백질과 
caspase-3 단백질의 분해 검출을 통해 HepG2 세포에서 자연 사멸이 
발생함을 확인하였다. 한편, 자가포식과 관련된 단백질을 측정한 결과 
콜레스테롤의 처리는 LC3-II, p62 단백질의 유의적인 증가를 일으켰으며 
Beclin-1 단백질은 차이가 없었다. 또한, 라이소좀 저해제인 chloroquine을 
함께 처리하여 관찰한 결과 자가포식 유동양(autophagic flux)이 
콜레스테롤을 처리하지 않았을 경우에 비해 현저하게 감소함을 확인하였고, 
동시에 자가포식의 분해물로 지정된 ubiquitinated protein의 축적이 
일어남을 확인하였다. 자가포식의 저해는 caspase-3 활성을 일으켜 세포 
자연 사멸을 초래한다고 알려져 있으므로 자가포식의 저해가 콜레스테롤에 
의한 세포 독성의 주요 기전인지 확인하기 위해 chloroquine과 
콜레스테롤을 처리하여 MTT assay를 통해 세포 활성을 시험하였다. 그 
결과 50 µg/mL 농도의 콜레스테롤과 10 µM 농도의 chloroquine 처리의 
자가포식 저해 정도가 비슷한 수준인 것과 달리 chloroquine의 단독 
처리는 경미한 세포 활성 저해만을 나타내어 자가포식 이외에 세포 사멸을 
초래하는 콜레스테롤의 독성 기전이 있음을 확인하였다. 실험 결과, 50 
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µg/mL 농도의 콜레스테롤의 처리가 세포 내 활성 산소와 지질 과산화물의 
증가로 대변되는 산화스트레스 지표의 유의적인 변화를 일으킴을 확인했다. 
또한, 산화스트레스와 관련하여 JNK 단백질의 인산화 증가를 관찰하였고, 
이와 연관이 깊은 비정상적인 미토콘드리아의 지표로서 cleaved caspase-9 
단백질 수준의 증가를 확인하였으며, ATP 고갈의 간접적인 증거로서 
AMPK 인산화형의 증가를 확인하였다. 결론적으로, 본 실험에서 과다한 
간의 콜레스테롤 축적은 자가포식 유동성을 감소시키고 산화스트레스 및 
미토콘드리아 이상을 일으켜 세포 자연 사멸을 촉진함을 확인하였다. 비록 
감소한 자가포식 활성 그 자체가 전적으로 간세포 사멸을 일으키진 
않았지만, 비정상적인 미토콘드리아 제거를 저해시켜 산화 스트레스로 
표현되는 세포 독성을 증가시켰을 가능성이 있다. 전체적으로 본 연구는 
기존에 비알콜성 간질환에서 독성 물질로 연구된 유리 지방산 이외에 
콜레스테롤 역시 간 세포에 직접적으로 독성을 일으킬 수 있음을 
확인하였고, 비알콜성 간질환에서 나타나는 자가 포식 저해 현상에 
콜레스테롤이 기여할 수 있음을 처음으로 확인한 데에 의의가 있다.  
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